Product Information
ARIPIPRAZOLE 1 MG/ML SOLUTION is a generic product labeled by Apotex Corp., priced at $0.3312 per ML under NDC 60505040405. Its NADAC has been published 556 times since Feb 10, 2016.
FDA first approved this application on Sep 30, 2015. Its Orange Book therapeutic-equivalence code is AA.
Strength
1 mg/mL
Manufacturer
Apotex Corp.NDC
60505040405
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ARIPIPRAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA204094FDA Approved
9/30/2015
TE Code
AA
On Market Since
10/8/2015
Pharmacological Classes
Price Statistics
The NADAC for ARIPIPRAZOLE 1 MG/ML SOLUTION has been published 556 times since Feb 10, 2016, and over the history we have for it it has declined 93.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3312 per ML |
|---|---|
| All-time high | $5.0313 (May 11, 2016) |
| All-time low | $0.3131 (Aug 19, 2026) |
| 52-week high | $0.5159 |
| 52-week low | $0.3131 |
| Median price | $1.2875 |
| Average price | $1.8857 |
| Largest weekly change | +55.1% (Mar 22, 2023) |
| Weeks tracked | 556 |
| Tracking since | Feb 10, 2016 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the aripiprazole market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Apotex Corp. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
aripiprazole market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Atypical Antipsychotic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ARIPIPRAZOLE 1 MG/ML SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for ARIPIPRAZOLE 1 MG/ML SOLUTION, manufactured by Apotex Corp., is $0.3312 per ML (NDC 60505040405), effective Sep 30, 2026.
How has the price of ARIPIPRAZOLE 1 MG/ML SOLUTION changed over time?
Over the history we have for it, the NADAC for ARIPIPRAZOLE 1 MG/ML SOLUTION has declined 93.2%. It has been tracked across 556 weekly CMS publications since Feb 10, 2016.
What are the highest and lowest recorded NADAC prices for ARIPIPRAZOLE 1 MG/ML SOLUTION?
Since Feb 10, 2016, the NADAC for ARIPIPRAZOLE 1 MG/ML SOLUTION has ranged from a low of $0.3131 (Aug 19, 2026) to a high of $5.0313 (May 11, 2016), with a median of $1.2875 per ML.
Are there cheaper alternatives to ARIPIPRAZOLE 1 MG/ML SOLUTION?
No other NADAC-published product currently shares the active ingredient and strength of ARIPIPRAZOLE 1 MG/ML SOLUTION in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ARIPIPRAZOLE 1 MG/ML SOLUTION?
ARIPIPRAZOLE 1 MG/ML SOLUTION (NDC 60505040405) is labeled by Apotex Corp., and CMS classifies it as a generic product.